[Palliative treatment of rectal carcinoma using a urologic resectoscope].
OBJECTIVE
The aim of this study was to report our experience with endoscopic transanal resection (ETAR) using a urologic resectoscope for palliative treatment of rectal carcinoma.


METHODS
Outcome in patients who underwent ETAR with a urologic resectoscope between October 1992 and March 1999 are reported.


RESULTS
The 60 ETAR procedures were performed in 37 patients (19 men and 18 women, median age 82 years). Morbidity was 10% (6 patients) and mortality was 2.7% (1 patient). Median hospital stay for the procedure was 5 days. Symptom control was achieved in 86% of the patients (40% partial control, 46% complete control). Colostomy was performed in 8 patients 7 months after ETAR. At study end, 4 patients were alive. Median survival was 14 months (range 0 - 62). The 1-, 2-, and 5-year survival rates were 54, 32 and 5%, respectively.


CONCLUSIONS
ETAR is a simple, minimally invasive and economical method for palliative treatment of patients with rectal carcinoma. ETAR is a useful addition to the surgeon's armamentarium.
Ziani
M
M
Département de Chirurgie Digestive, Centre Hospitalier Universitaire, Angers, France.
Tuech
J J
JJ
Chautard
D
D
Regenet
N
N
Pessaux
P
P
Randriamananjo
S
S
Arnaud
J P
JP
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D000368:Aged; D000369:Aged, 80 and over; D001003:Anal Canal; D003125:Colostomy; D019723:Endoscopes; D004724:Endoscopy; D005260:Female; D006801:Humans; D008297:Male; D010166:Palliative Care; D011467:Prostate; D012004:Rectal Neoplasms / Q000401:mortality / Q000601:surgery*; D015996:Survival Rate